Med Page Today
FEBRUARY 22, 2024
(MedPage Today) -- I have received some unusual phone calls in my nearly 40-year career as a psychiatrist, but Mary's* call was unique. "Dr. Liester," she began, "I don't need to see you as a patient. I just want you to tell me if I'm crazy. You.
Dr. Smith's ECG Blog
FEBRUARY 22, 2024
Written by Pendell Meyers A woman in her 30s called EMS for acute symptoms including near-syncope, nausea, diaphoresis, and abdominal pain. EMS arrived and found her to appear altered, critically ill, and hypotensive. An ECG was performed: What do you think? Extremely wide complex monomorphic rhythm just over 100 bpm. The QRS is so wide and sinusoidal that the only real possibilities left are hyperkalemia or Na channel blockade.
Med Page Today
FEBRUARY 22, 2024
(MedPage Today) -- Patients should not use smartwatches or smart rings alone to measure blood glucose levels, the FDA warned on Wednesday. Noninvasive devices that do not rely on finger-pricks or pierce the skin are not authorized, cleared, or.
HCPLive
FEBRUARY 22, 2024
A new study found people with depression are associated with an increased risk of gout. However, not many people with both depression and gout sought out treatment (0.2%).
NOVARAD
FEBRUARY 22, 2024
Many healthcare directors in today’s economic landscape are facing complications with staff shortages , IT challenges, and inefficient processes. Enterprise imaging is one of the primary solutions hospitals are finding in their search for methods to improve services for patients and work for healthcare professionals.
DAIC
FEBRUARY 22, 2024
REHAB-HFpEF is a Phase III study led by Dalane Kitzman, M.D., (front) professor of cardiovascular medicine at Wake Forest University School of Medicine. Photo courtesy of Wake Forest University School of Medicine milla1cf Thu, 02/22/2024 - 13:51 February 22, 2024 — Wake Forest University School of Medicine , the academic core of Advocate Health , is expanding another research study to Advocate Christ Medical Center , in Oak Lawn, Illinois, just outside Chicago.
HCPLive
FEBRUARY 22, 2024
Robert Wood, MD, discusses how the FDA approval of omalizumab (Xolair) changes the management of pediatric food allergy and what type of hurdles to optimal uptake the community may encounter.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
FEBRUARY 22, 2024
Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early. Photo courtesy of The Ohio State University Wexner Medical Center milla1cf Thu, 02/22/2024 - 13:45 February 22, 2024 — About 1 in 250 Americans have dilated cardiomyopathy (DCM), a type of in
Medical Xpress - Cardiology
FEBRUARY 22, 2024
Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest. Now, researchers and clinicians at Mayo Clinic are using artificial intelligence (AI) technology to flag heart problems earlier, boosting the abilities of a diagnostic test that has been around for over a century—the electrocardiogram (ECG).
Becker's Hospital Review - Cardiology
FEBRUARY 22, 2024
York, Pa.-based WellSpan Health is expanding vascular surgery services in four cities by adding four vascular surgeons and three satellite offices.
American Heart News - Heart News
FEBRUARY 22, 2024
Statement Highlights: A new American Heart Association scientific statement updates more than a decade of research identifying, managing and preventing neurodevelopmental delays and disorders among people with congenital heart disease. The new.
HCPLive
FEBRUARY 22, 2024
Among patients aged 40 – 49 years, asymptomatic hyperuricemia was linked to incident arthritis.
Medical Xpress - Cardiology
FEBRUARY 22, 2024
New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with type 2 diabetes.
Circulation
FEBRUARY 22, 2024
Circulation, Ahead of Print. Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease. In addition, best practices for evaluation and management of developmental delays and disorders in this high-risk patient population have been formulated based on literature review and expert consensus.
Medical Xpress - Cardiology
FEBRUARY 22, 2024
A recent clinical trial reveals how a daily statin pill may prevent heart attacks and strokes in people with HIV. In this substudy of the phase 3 Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), a team led by investigators at Massachusetts General Hospital (MGH) discovered that pitavastatin reduces plaque buildup in the heart's coronary arteries and lowers inflammation in the blood.
Frontiers in Cardiovascular Medicine
FEBRUARY 22, 2024
Introduction Volume overload from mitral regurgitation can result in left ventricular systolic dysfunction. To prevent this, it is essential to operate before irreversible dysfunction occurs, but the optimal timing of intervention remains unclear. Current echocardiographic guidelines are based on 2D linear measurement thresholds only. We compared volumetric CT-based and 2D echocardiographic indices of LV size and function as predictors of post-operative systolic dysfunction following mitral repa
Medical Xpress - Cardiology
FEBRUARY 22, 2024
A study conducted by scientists from Kaunas (Lithuania) universities has revealed the possibility of non-invasively reducing blood pressure and speeding up gas exchange within the pulmonary system. The findings were confirmed in vivo—within 7 minutes, lung oxygen saturation of the test subjects improved by more than 10–15%, and blood pressure and heart rate decreased.
American College of Cardiology
FEBRUARY 22, 2024
Does coronary artery calcium (CAC) score ≥1,000 (Agatston units) in persons with one or more atherosclerotic cardiovascular disease (ASCVD) risk factors warrant treatment as very high risk requiring more intense lipid lowering and other medical therapy?
Medical Xpress - Cardiology
FEBRUARY 22, 2024
Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids can deposit in any tissue or organ, including the heart, kidneys, liver and nerves. When it occurs in the heart, it's called cardiac amyloidosis.
Hypertension Journal
FEBRUARY 22, 2024
Hypertension, Ahead of Print. BACKGROUND:The extent to which a history of hypertensive disorders of pregnancy is associated with incident cardiovascular disease also among women with diabetes is unknown.METHODS:In this nationwide register-based cohort study, parous women aged 18 to 69 years with a first delivery in the Swedish Medical Birth Register, regardless of diabetic status at that time, and a subsequent clinical visit in the Swedish National Diabetes Register were included.
Medical Xpress - Cardiology
FEBRUARY 22, 2024
Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology.
Frontiers in Cardiovascular Medicine
FEBRUARY 22, 2024
Introduction Out-of-office blood pressure (BP) monitoring is increasingly valuable in the diagnosis and management of hypertension. With advances in wearable BP technologies, the ability to gain insight into BP outside of traditional centers of care has expanded greatly. Methods Here we explore the usability of a novel, wrist-worn BP cuff monitor for out-of-office data collection with participants following digital cues rather than in-person instruction.
HCPLive
FEBRUARY 22, 2024
Urate-lowering therapy and dosing regimen impact the risk of gout flares, with greater fixed dosing linked to a greater risk of flares and prophylaxis associated with reductions in flare risk.
Frontiers in Cardiovascular Medicine
FEBRUARY 22, 2024
Objective It is advised that patients engage in physical activity to enhance their quality of life and achieve better results. The purpose of the current study was to measure the efficacy of exercise on the physical ability, cardiac function and cardiopulmonary fitness of patients with AF. Method A comprehensive systematic literature search was performed in PubMed, Embase, and Web of Science from 1991 to 2023 for RCTs comparing physical exercise combined with AF routine treatments to routine tre
HCPLive
FEBRUARY 22, 2024
A new study found the odds of gout were 2.65 times greater in patients with OSA than in patients without OSA.
Frontiers in Cardiovascular Medicine
FEBRUARY 22, 2024
Aims Perioperative stroke remains a devastating complication after transcatheter aortic valve implantation (TAVI), and using a cerebral embolic protection device (CEPD) during TAVI may reduce the occurrence of stroke according to some studies. Therefore, we conducted this meta-analysis to determine whether CEPD should be routinely used during TAVI. Methods and results The inclusion criteria for this study were randomized controlled trials (RCTs) that examined the outcome of stroke with or withou
Dr. S. Venkatesan MD
FEBRUARY 22, 2024
Recently , I received two e-mail invite for two major conferences one in India other in Europe. Once upon a time, in 1990s we as fellows used to attend these conference for Rs 1000 (15 Euros/Dollors). Now it is 50-75(5000-7500%times increased) Even few years ago it was affordable. I don’t know how many of us can think to attend such conferences.
HCPLive
FEBRUARY 22, 2024
These data contribute to existing research into links observed between rheumatic diseases such as gout and cardiovascular disease among Indigenous North American populations.
NEJM Journal Watch - Cardiology
FEBRUARY 22, 2024
Ten-year follow-up of an “all-comers” randomized trial demonstrates no difference in clinical outcomes between TAVR and SAVR.
American College of Cardiology
FEBRUARY 22, 2024
The U.S. Food and Drug Administration (FDA) last year approved of ultrasound and radiofrequency ablation-based renal denervation devices that can be used to “reduce blood pressure as an adjunctive treatment in patients with uncontrolled hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure.
HCPLive
FEBRUARY 22, 2024
Often considered a cause of symptom onset in musculoskeletal conditions, a new study found that weather factors do not appear to be a risk factor for pain.
NEJM Journal Watch - Cardiology
FEBRUARY 22, 2024
In a case-control study, stimulant use was associated with hypertension, but not arrhythmia or ischemic heart disease.
DAIC
FEBRUARY 22, 2024
tim.hodson Thu, 02/22/2024 - 11:09 On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." The webinar will take place at 1 p.m. eastern time and is sponsored by Optum. Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
Open Heart
FEBRUARY 22, 2024
Background High blood pressure (BP) is a major risk factor for cardiovascular disease (CVD). Adequate treatment of high BP should reduce the risk of CVD, but this association has seldom been assessed in a general population setting. Methods Population-based prospective study conducted in Lausanne, Switzerland, with a follow-up between 2003 and 2021.
DAIC
FEBRUARY 22, 2024
tim.hodson Thu, 02/22/2024 - 11:09 On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." The webinar will take place at 1 p.m. eastern time and is sponsored by Optum. Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
Open Heart
FEBRUARY 22, 2024
Objective The objective of this article is to evaluate near-infrared spectroscopy (NIRS), a non-invasive technique to assess tissue oxygenation and mitochondrial function, as a diagnostic tool for statin-associated muscle symptoms (SAMS). Methods We verified SAMS in 39 statin-treated patients (23 women) using a double-blind, placebo-controlled, cross-over protocol.
HCPLive
FEBRUARY 22, 2024
A recent study points to a link between bisphenol exposure and elevated uric acid levels, with implications for gout risk, especially in women.
Expert insights. Personalized for you.
140 
Let's personalize your content